Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic neuropathies.

A I Vinik1, Anahit Mehrabyan

  • 1Department of Internal Medicine, The Strelitz Diabetes Institutes, Eastern Virginia Medical School, 855 West Brambleton Avenue, Norfolk, VA 23510, USA. vinikai@evms.edu

The Medical Clinics of North America
|August 17, 2004
PubMed
Summary

Diabetic neuropathy (DN) is a common diabetes complication with uncertain epidemiology due to unclear definitions. Understanding its pathogenic processes is key to managing this disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective review of patients with myasthenia gravis switched from plasma exchange therapy to efgartigimod treatment.

Muscle & nerve·2024
Same author

Disease-Based Prognostication: Myasthenia Gravis.

Seminars in neurology·2023
Same author

Bilateral Acute Hippocampal Ischemia in Two Patients Abusing Cocaine: What is the Outcome?

Cureus·2022
Same author

Managing Myasthenia Gravis with Eculizumab Monotherapy Through Pregnancy.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2022
Same author

A Case of MuSK Myasthenia Gravis Presenting With Persistent Respiratory Insufficiency.

Journal of clinical neuromuscular disease·2021
Same author

Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation.

JCI insight·2021

Area of Science:

  • Neurology
  • Endocrinology
  • Pathophysiology

Background:

  • Diabetic neuropathy (DN) is a frequent diabetes complication, contributing significantly to patient morbidity and mortality.
  • The understanding of DN's epidemiology and natural progression is hindered by inconsistent definitions and measurement methods.
  • Current research explores vascular, oxidative stress, neurotrophic, and autoimmune factors in DN pathogenesis.

Purpose of the Study:

  • To clarify the epidemiological and natural history of diabetic neuropathy.
  • To investigate the underlying pathogenic mechanisms of diabetic neuropathy.
  • To identify potential therapeutic interventions for diabetic neuropathy.

Main Methods:

  • Review of existing literature on diabetic neuropathy definitions and measurements.
  • Analysis of studies investigating vascular, oxidative stress, neurotrophic, and autoimmune hypotheses.
  • Synthesis of current understanding of DN pathogenesis.

Main Results:

  • Significant uncertainty exists regarding the definition and measurement of diabetic neuropathy.
  • Multiple hypotheses, including vascular, oxidative stress, neurotrophic, and autoimmune factors, are under investigation.
  • Unraveling pathogenic processes is crucial for effective management of DN.

Conclusions:

  • Further research is needed to establish standardized definitions and measurement tools for DN.
  • Investigating the proposed pathogenic mechanisms may reveal novel therapeutic targets.
  • Successful management of diabetic neuropathy hinges on a comprehensive understanding of its underlying causes.

Related Experiment Videos